Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04188145
Title A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer (BEVAMAINT)
Acronym BEVAMAINT
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Centre Hospitalier Universitaire Dijon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.